Literature DB >> 23002924

Cytotoxic iridoids from the roots of Patrinia scabra.

Ning Li1, Lei Di, Wen-Chao Gao, Kai-Jin Wang, Ling-Bo Zu.   

Abstract

Six new iridoid glucosides, patriridosides D-I (1-6), and one new iridoid, scabrol A (7), along with 12 known non-glycosidic and glycosidic iridoids (8-19), have been isolated from an ethanolic extract of the roots of Patrinia scabra. The cytotoxic activity of the isolated compounds against human cervical carcinoma HeLa cells and gastric carcinoma MNK-45 cells was evaluated using the MTT assay. Compounds 1, 4-6, 8, and 18 showed cytotoxic activities against the MNK-45 cell line with respective IC₅₀ values of 15.6, 8.7, 9.4, 30.9, 23.8, and 11.2 μM, while only compound 10 showed cytotoxicity against the HeLa cell line, with an IC₅₀ value of 24.5 μM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23002924     DOI: 10.1021/np300286t

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Optimization for ultrasonic-microwave synergetic extraction of total iridoid glycosides and screening of analgesic and anti-inflammatory active fractions from patrinia scabra Bunge (Valerianaceae).

Authors:  Quhuan Ma; Yanmei Lu; Yi Deng; Xiaodong Hu; Wanyu Li; Hongzhen Jia; Yuer Guo; Xiaofeng Shi
Journal:  BMC Complement Med Ther       Date:  2022-01-04

2.  The Antitumor Constituents from Hedyotis Diffusa Willd.

Authors:  Changfu Wang; Xuegang Zhou; Youzhi Wang; Donghua Wei; Chengjie Deng; Xiaoyun Xu; Ping Xin; Shiqin Sun
Journal:  Molecules       Date:  2017-11-30       Impact factor: 4.411

3.  Separation and Identification of Four New Compounds with Antibacterial Activity from Portulaca oleracea L.

Authors:  Xia Lei; Jianmin Li; Bin Liu; Ning Zhang; Haiyang Liu
Journal:  Molecules       Date:  2015-09-10       Impact factor: 4.411

4.  Cytotoxic and Apoptotic Activities of Methanolic Subfractions of Scrophularia oxysepala against Human Breast Cancer Cell Line.

Authors:  Mona Orangi; Ardalan Pasdaran; Dariush Shanehbandi; Tohid Kazemi; Bahman Yousefi; Behnaz-Alsadat Hosseini; Behzad Baradaran
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-29       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.